L-R: Professor Fergal O’Brien, RCSI Director of Research; Professor Steven Kerrigan, June Ryan, 3M Ireland Country Leader; Professor James O’Donnell; Keith O’Connor, 3M Head of Business Development; Ms Aine Gibbons, RCSI Director of Development and Alumni Relations; and Chris Lessing, Medical Affairs Leader for 3M+KCI
Studies to investigate micro blood clots within the lung and the ability of ability of a repurposed drug to slow or stop the virus from causing severe damage leading to sepsis/septic shock
Science-based technology company 3M has awarded a significant philanthropic research grant of €420,000 to RCSI University of Medicine and Health Sciences to advance scientific knowledge in the global response to the COVID-19 pandemic.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
